Dietary Total Antioxidant Capacity and Risk of Polycystic Ovary Syndrome: A Case-Control Study

Document Type : Original Article


1 Department of Nutrition, School of Medical Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran

2 Department of Cellular and Molecular Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Student Research Committee, Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

4 Department of Nutrition and Food Science, California State University, Chico, CA 95929, USA


Background: Among multiple factors that affect the etiology of polycystic ovary syndrome (PCOS), diet has
an important contribution. Chronic oxidative stress has also been implicated in the development of PCOS. The
present study is an attempt to evaluate dietary total antioxidant capacity (TAC) and its relationship with odds of
PCOS in Iran.
Materials and Methods: The study was carried out as a case-control study in hospital outpatient clinics, Tehran,
Iran. Totally, 310 female participants with a history of PCOS and 602 age-matched controls took part in this
study between June 2015 and December 2018. A reproducible and valid 168-item semi-quantitative food frequency
inventory was utilized to determine the entire antioxidants of the usual diet in order to calculate dietary
TAC. The relationship of dietary TAC with odds of PCOS were assessed adjusting for potential confounders
through an estimation of two multivariable conditional regression models. The first tertile was presented as a
reference category.
Results: In a fully adjusted model, the highest tertile of dietary TAC was associated with a reduced odds of
PCOS [odds ratio (OR): 0.81, 95% confidence interval (95% CI): 0.59, 0.96, P for trend: 0.038). In addition, PCOS odds decreased in the highest tertile of α-tocopherol intake (OR: 0.73, 95% CI: 0.56, 0.88, P for trend:
0.023). The adjusted ORs in the highest tertile of vitamin C, β-carotene and magnesium were 0.79 (95% CI: 0.83-0.97), 0.81 (95% CI: 0.67-0.98) and 0.91 (95% CI: 0.55-0.9 8) respectively, with a significant trend.
Conclusion: Our results provide evidence that there was a relationship between high TAC diets and lower odds of


  1. Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019; 42(4): 560-567.
  2. Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosravi H. The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: a randomized clinical trial. Iran J Reprod Med. 2013; 11(8): 665-672.
  3. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986; 62(5): 904-910.
  4. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988; 123(2): 733- 739.
  5. Var A, Kuşcu NK, Koyuncu F, Uyanik BS, Onur E, Yildirim Y, et al. Atherogenic profile in preeclampsia. Arch Gynecol Obstet. 2003; 268(1): 45-47.
  6. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003; 80(1): 123-127.
  7. Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016; 2016: 8589318.
  8. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001; 34(5): 407-413.
  9. Combelles CM, Gupta S, Agarwal A. Could oxidative stress influence the in-vitro maturation of oocytes? Reprod Biomed Online. 2009; 18(6): 864-880.
  10. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013; 6: 1-13.
  11. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013; 98(12): 4565-4592.
  12. Aquino CI, Nori SL. Complementary therapy in polycystic ovary syndrome. Transl Med UniSa. 2014; 9: 56-65.
  13. Shahrokhi SA, Naeini AA. The association between dietary antioxidants, oxidative stress markers, abdominal obesity and polycystic ovary syndrome: a case control study. J Obstet Gynaecol. 2020; 40(1): 77-82.
  14. Noormohammadi M, Eslamian G, Malek S, Shoaibinobarian N, Mirmohammadali SN. The association between fertility diet score and polycystic ovary syndrome: a case-control study. Health Care Women Int. 2022; 43(1-3): 70-84.
  15. Eslamian G, Hekmatdoost A. Nutrient patterns and risk of polycystic ovary syndrome. J Reprod Infertil. 2019; 20(3): 161-168.
  16. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity: a novel indicator of diet quality in healthy young adults. J Am Coll Nutr. 2009; 28(6): 648- 656.
  17. Besagil PS, Calapkorur S, Sahin H. Determination of the relationship between total antioxidant capacity and dietary antioxidant intake in obese patients. Niger J Clin Pract. 2020; 23: 481-488.
  18. Kim K, Vance TM, Chun OK. Greater total antioxidant capacity from diet and supplements is associated with a less atherogenic blood profile in U.S. adults. Nutrients. 2016; 8(1): 15.
  19. Zhong GC, Pu JY, Wu YL, Yi ZJ, Wan L, Wang K, et al. Total antioxidant capacity and pancreatic cancer incidence and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2020; 29(5): 1019-1028.
  20. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19(1): 41-47.
  21. Safari A, Shariff ZM, Kandiah M, Rashidkhani B, Fereidooni F. Dietary patterns and risk of colorectal cancer in Tehran province: a case-control study. BMC Public Health. 2013; 13: 222.
  22. Eslamian G, Baghestani AR, Eghtesad S, Hekmatdoost A. Dietary carbohydrate composition is associated with polycystic ovary syndrome: a case-control study. J Hum Nutr Diet. 2017; 30(1): 90-97.
  23. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010; 13(5): 654-662.
  24. Haytowitz DB, Bhagwat S. USDA database for the oxygen radical absorbance capacity (ORAC) of selected foods, Release 2. USDA. Beltsbille; 2010.
  25. Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, et al. Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019; 11(10): 2278.
  26. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med. 2015; 13(1): 1-8.
  27. Verit FF, Erel O, Kocyigit A. Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2007; 88(2): 418-424.
  28. Kanafchian M, Esmaeilzadeh S, Mahjoub S, Rahsepar M, Ghasemi M. Status of serum copper, magnesium, and total antioxidant capacity in patients with polycystic ovary syndrome. Biol Trace Elem Res. 2020; 193(1): 111-117.
  29. Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019; 62(5): 335-343.
  30. Ghowsi M, Khazali H, Sisakhtnezhad S. The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: An experimental study. Int J Reprod Biomed. 2018; 16(3): 149-158.
  31. Yalçınkaya E, Cakıroğlu Y, Doğer E, Budak O, Cekmen M, Calışkan E. Effect of follicular fluid NO, MDA and GSH levels on in vitro fertilization outcomes. J Turk Ger Gynecol Assoc. 2013; 14(3): 136-141.
  32. Nuñez-Calonge R, Cortés S, Gutierrez Gonzalez LM, Kireev R, Vara E, Ortega L, et al. Oxidative stress in follicular fluid of young women with low response compared with fertile oocyte donors. Reprod Biomed Online. 2016; 32(4): 446-456.
  33. Ressler IB, Grayson BE, Ulrich-Lai YM, Seeley RJ. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab. 2015; 308(12): E1076-1084.
  34. Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, et al. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2016; 207: 214-219.
  35. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(3): 1337-1344.
  36. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005; 3: 28.
  37. Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res. 2015; 47(3): 232-238.
  38. Pirouzeh R, Heidarzadeh-Esfahani N, Morvaridzadeh M, Izadi A, Yosaee S, Potter E, et al. Effect of DASH diet on oxidative stress parameters: a systematic review and meta-analysis of randomized clinical trials. Diabetes Metab Syndr. 2020; 14(6): 2131-2138.
  39. Salama AA, Amine EK, Salem HA, Abd El Fattah NK. Antiinflammatory dietary combo in overweight and obese women with polycystic ovary syndrome. N Am J Med Sci. 2015; 7(7): 310-316.
  40. Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013; 98(6): E1088-1096.